Corbus Pharmaceuticals Holdings (CRBP) Current Leases (2018 - 2025)

Corbus Pharmaceuticals Holdings has reported Current Leases for 8 years, with the latest figure at $1.6 million in Q4 2025.

• On a quarterly basis, Current Leases rose 1.68% year-over-year to $1.6 million in Q4 2025; TTM through Dec 2025 was $1.6 million, a 1.68% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 1.68% from the prior year.
• Current Leases was $1.6 million for Q4 2025 at Corbus Pharmaceuticals Holdings, down from $1.7 million in the prior quarter.
• The five-year high for Current Leases was $1.7 million in Q3 2025, with the low at $1.0 million in Q1 2021.
• Average Current Leases over 5 years is $1.4 million, with a median of $1.4 million recorded in 2023.
• The sharpest annual moves came in 2021 and 2025: Current Leases jumped 39.49% in 2021, then increased 1.68% in 2025.
• Over 5 years, Current Leases stood at $1.1 million in 2021, then rose by 12.66% to $1.3 million in 2022, then increased by 12.19% to $1.4 million in 2023, then increased by 11.76% to $1.6 million in 2024, then gained by 1.68% to $1.6 million in 2025.
• The last three Current Leases figures came in at $1.6 million (Q4 2025), $1.7 million (Q3 2025), and $1.7 million (Q2 2025), per Business Quant data.